KING PHARMACEUTICALS INC

Research KING PHARMACEUTICALS INC (KG) on Bullrun: market cap USD 68.85M, P/E 0.8. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerKG
• ExchangeNASDAQ
• CountryBermuda
• SectorFinancial Services
• IndustryInsurance-Reinsurance
• CurrencyUSD
• Market capUSD 68.85M
• P/E0.8
• Financial periodFY2025
• RevenueUSD 34.05M
• Revenue growth785.1%
• Net incomeUSD 46.73M

Valuation Snapshot

latest market cap is USD 68.85M; P/E is 0.8.

About KING PHARMACEUTICALS INC

Kestrel Group Ltd engages in provision of fronting services to insurance program managers, managing general agencies, reinsurers, and reinsurance brokers in Bermuda. The company operates through two segments: Program Services and Legacy Reinsurance. The company is based in Hamilton, Bermuda.

Frequently asked questions

What is KING PHARMACEUTICALS INC's market cap?

KING PHARMACEUTICALS INC's market capitalization is USD 68.85M.

What is KING PHARMACEUTICALS INC's P/E ratio?

KING PHARMACEUTICALS INC's price-to-earnings (P/E) ratio is 0.8.

What does KING PHARMACEUTICALS INC do?

Kestrel Group Ltd engages in provision of fronting services to insurance program managers, managing general agencies, reinsurers, and reinsurance brokers in Bermuda. The company operates through two segments: Program Services and Legacy Reinsurance. The company is based in Hamilton, Bermuda.